Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Amid Opioid Crisis, Spero Health Brings Vital Addiction Treatment Services to Chattanooga

Published

on

Reading Time: 3 minutes

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Spero Health, a national leader in outpatient addiction treatment and a
CARF-accredited organization that specializes in local, affordable,
outpatient care for individuals suffering from substance use disorders,
announced the opening of a new clinic in Chattanooga, located at 7030
Lee Highway, Suite 201. The Chattanooga clinic is the organization’s 26th
outpatient location and is expected to start seeing new patients at the
end of June. Appointments are available now, and individuals are
encouraged to call (423) 301-5930 or stop by the Lee Highway location
for more information.

The opening of the Chattanooga clinic comes at a critical time as Spero
Health meets the growing demand for a local, high-quality and affordable
option to treat addiction. Spero Health accepts TennCare and
participates with select commercial insurance plans so that individuals
suffering can seek help immediately without the cost barrier to
treatment.

Spero Health has appointed Dr. Lisa Fara, who is fellowship trained in
Addiction Medicine, as the Chattanooga medical director. She joins the
organization with an extensive background focused on substance use
disorders, treatment and prevention, and will be the lead physician at
this new location. After many years of practicing as a board-certified
family physician, Dr. Fara furthered her knowledge and proficiency by
completing a fellowship in Addiction Medicine, qualifying her to provide
comprehensive and experienced addiction medical care to patients through
such modalities as medical detoxification and medication-assisted
therapy, as well as ongoing, in-depth addiction care for patients in
both inpatient and outpatient settings.

Dr. Fara describes the disease of addiction as an “individual,
desperate, internal struggle that each patient (and their loved ones)
experiences,” and she cites the current definition of addiction put
forth by ASAM: “Addiction is a primary, chronic disease of brain reward,
motivation, memory and related circuitry. Dysfunction in these circuits
leads to characteristic biological, psychological, social and spiritual
manifestations.”

Data released by the Tennessee Department of Health shows deaths from
overdoses have been steadily increasing year after year as the opioid
epidemic grips the nation. Chattanooga is ranked 20th among the worst 25
cities in the U.S. for opioid prescription abuse. The state has expanded
resources to address the epidemic, and leaders from Spero Health believe
they can be part of the solution as there is a considerable need for
high-quality treatment providers locally.

“Tennessee communities have been hit extremely hard by the drug
epidemic, and the landscape of the types of drugs individuals are using
is changing rapidly,” said Steve Priest, CEO of Spero Health. “We have
heard from payors, state officials and healthcare partners about the
need for access to quality care close to home, and are committed to
bringing local, affordable and comprehensive solutions to communities
across the state that can meet the needs of those struggling with opioid
addiction and other substances,” Priest added.

Dr. Fara added, “We are deeply aware that not treating addiction
appropriately has dire ripple effects in our local and national
communities. Our most current scientific and evidenced-based knowledge
regarding effective addiction treatment tells us that this disease
requires comprehensive, sustained and collaborative medical and
psychosocial therapeutics. The community-based options that Spero Health
offers — with the utilization of multiple modalities including
medication, recovery support services and focused addiction and related
counseling strategically — position the organization to better help
patients successfully manage their chronic condition.”

For more information about Spero Health please visit www.sperohealth.com.

About Spero Health

Spero Health, Inc., is an integrated healthcare services organization
specializing in local and affordable outpatient care for individuals
suffering from substance use disorders with a mission to “Save Lives,
Instill Hope, and Restore Relationships.”
Spero Health utilizes an
innovative evidenced-based integrated care model that combines both
physical and behavioral healthcare services under one roof to treat the
whole patient. This integrated care model combines physician services
(including medication-assisted treatment), behavioral health counseling,
recovery support services, medication management and patient and family
education. Its community-based approach to treatment allows patients to
continue working and caring for their families as they overcome
addiction.

Based in Nashville, Tenn. and privately held by Heritage Group, Health
Velocity Capital, South Central, Inc. and Frist Cressey Ventures, Spero
Health operates 26 freestanding outpatient clinics located throughout
Kentucky, Ohio, Indiana and Tennessee. Providing care for more than
5,600 patients each month, Spero is one of the largest office-based
opioid treatment providers in the country and is in network with
Medicaid and most commercial insurance plans.

For more information about Spero Health, please visit www.sperohealth.com.

Contacts

Ginger Jackson
Spero Health
[email protected]
(859)
209-2296


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III

Published

on

Continue Reading

Humboldt

Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace

Published

on

humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace

Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia

SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.

The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.

Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.

“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”

Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”

About Humboldt Seed Company

Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.

For more information visit https://humboldtseedcompany.com/.

About Apollo Green

Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics. 

For more information visit https://apollogreen.com/.

Media contact
Jaana Prall
[email protected] 

Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html

Continue Reading

Cannabis

Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania